BioCentury | Jul 23, 2015
Tools & Techniques

Gene therapy's coming of age

...plasmids in clinical development: BioCancell Therapeutics Inc. , Celsion Corp. , Copernicus Therapeutics Inc. , Human Stem Cells Institute...
BioCentury | Jun 11, 2012
Clinical News

Celution 800 System regulatory update

...adipose-derived stem and regenerative cells (ADRCs) for plastic surgery and select soft tissue therapies. Partner Human Stem Cells Institute...
BioCentury | Dec 19, 2011
Clinical News

Neovasculgen cambiogenplasmid regulatory update

...Russia's Human Stem Cells Institute said Russia approved Neovasculgen cambiogenplasmid to treat peripheral arterial disease (PAD). The company plans...
...PAD). The company plans to launch the plasmid vector containing the VEGF gene in 2Q12. Human Stem Cells Institute...
BioCentury | Dec 5, 2011
Company News

SynBio, Rusnano hematology, endocrine/metabolic, infectious news

...a JV formed this year by a group comprised of the fund, Russian firms the Human Stem Cells Institute...
BioCentury | Dec 3, 2011
Financial News

Rusnano invests $28.7M in SynBio

...a JV formed this year by a group comprised of the fund; Russian firms the Human Stem Cells Institute...
BioCentury | Sep 20, 2010
Financial News

Human Stem Cells Institute proposes IPO

Human Stem Cells Institute , Moscow, Russia Business: Gene/Cell therapy, Supply/Service Date announced: 10/7/09 Type: IPO Shares: 15 million Price: RUB9-RUB11 Underwriter: CJSC Alor Invest Overallotment: TBD Note: A RUB10 price would raise RUB150 million ($5...
BioCentury | Jan 4, 2010
Finance

IPO performance

...IPO performance Company Date Raised Post-$ 12/31 mcap % chg Human Stem Cells Institute(MICEX:ISKJ) 12/10/09 $4.8 $23.9 $46.7 95%...
BioCentury | Oct 7, 2009
Financial News

Russia's HSCI planning IPO

Human Stem Cells Institute (Moscow, Russia) plans to sell 15 million shares at RUB9-RUB11 in an IPO underwritten by CJSC Alor Invest. A RUB10 price would raise RUB150 million ($5 million). HSCI expects to have...
Items per page:
1 - 8 of 8
BioCentury | Jul 23, 2015
Tools & Techniques

Gene therapy's coming of age

...plasmids in clinical development: BioCancell Therapeutics Inc. , Celsion Corp. , Copernicus Therapeutics Inc. , Human Stem Cells Institute...
BioCentury | Jun 11, 2012
Clinical News

Celution 800 System regulatory update

...adipose-derived stem and regenerative cells (ADRCs) for plastic surgery and select soft tissue therapies. Partner Human Stem Cells Institute...
BioCentury | Dec 19, 2011
Clinical News

Neovasculgen cambiogenplasmid regulatory update

...Russia's Human Stem Cells Institute said Russia approved Neovasculgen cambiogenplasmid to treat peripheral arterial disease (PAD). The company plans...
...PAD). The company plans to launch the plasmid vector containing the VEGF gene in 2Q12. Human Stem Cells Institute...
BioCentury | Dec 5, 2011
Company News

SynBio, Rusnano hematology, endocrine/metabolic, infectious news

...a JV formed this year by a group comprised of the fund, Russian firms the Human Stem Cells Institute...
BioCentury | Dec 3, 2011
Financial News

Rusnano invests $28.7M in SynBio

...a JV formed this year by a group comprised of the fund; Russian firms the Human Stem Cells Institute...
BioCentury | Sep 20, 2010
Financial News

Human Stem Cells Institute proposes IPO

Human Stem Cells Institute , Moscow, Russia Business: Gene/Cell therapy, Supply/Service Date announced: 10/7/09 Type: IPO Shares: 15 million Price: RUB9-RUB11 Underwriter: CJSC Alor Invest Overallotment: TBD Note: A RUB10 price would raise RUB150 million ($5...
BioCentury | Jan 4, 2010
Finance

IPO performance

...IPO performance Company Date Raised Post-$ 12/31 mcap % chg Human Stem Cells Institute(MICEX:ISKJ) 12/10/09 $4.8 $23.9 $46.7 95%...
BioCentury | Oct 7, 2009
Financial News

Russia's HSCI planning IPO

Human Stem Cells Institute (Moscow, Russia) plans to sell 15 million shares at RUB9-RUB11 in an IPO underwritten by CJSC Alor Invest. A RUB10 price would raise RUB150 million ($5 million). HSCI expects to have...
Items per page:
1 - 8 of 8